Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
None
Evaluation of Efficacy and Safety of Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis

This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in subjects with Idiopathic

carbon monoxide
diffusion capacity of the lung for carbon monoxide
pirfenidone
pamrevlumab
nintedanib
  • 374 views
  • 11 Nov, 2021
  • 228 locations
None
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in participants with

carbon monoxide
diffusion capacity of the lung for carbon monoxide
pirfenidone
pamrevlumab
nintedanib
  • 3 views
  • 14 Nov, 2021
  • 122 locations
None
A Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)

To evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids in subjects with non-ambulatory Duchenne muscular dystrophy (age 12 years and older

muscular dystrophy
absolute neutrophil count
calcium
prednisolone
pamrevlumab
  • 65 views
  • 29 Oct, 2021
  • 57 locations
None
A Phase 3 Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)

To evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids administered every two weeks in ambulatory subjects with Duchenne muscular

calcium
prednisolone
duchenne muscular dystrophy
corticosteroids
serum electrolyte
  • 2 views
  • 27 Oct, 2021
  • 52 locations
None
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Locally Advanced Pancreatic Cancer

This is a Phase 3, randomized, double-blind trial to evaluate the efficacy and safety of neoadjuvant treatment with pamrevlumab or placebo in combination with either gemcitabine plus nab

  • 8 views
  • 26 Sep, 2021
  • 92 locations